Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketamine and Propofol in ECT for Depression
NCT02305394Phase 4Unknown
- Sponsor
- First Affiliated Hospital of Chongqing Medical University
- Start
- Jan 2015
- Primary completion
- Dec 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ketamine in major depressive disorder (MDD), sponsored by First Affiliated Hospital of Chongqing Medical University. Status: unknown.
02
Drugs
ketamine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT02305394.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02305394.